Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Anticancer Research|August 1, 2018
Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast CancerTakaaki Masuda, Yoshiaki Shinden, Miwa Noda, et al.Surgical Case Reports|July 22, 2020
Primary monophasic synovial sarcoma of the cervical esophagus confirmed by detection of the SS18-SSX2 fusion transcripts: case report and literature reviewKen Sasaki, Masahiro Noda, Yusuke Tsuruda, et al.Anticancer Research|November 4, 2021
The Clinical Significance of CA19-9 and Tumor Size Ratios for Predicting Prognosis After Conversion Surgery in Patients With Stage IV Gastric CancerKeishi Okubo, Takaaki Arigami, Daisuke Matsushita, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[A Case of Adult Undifferentiated Sarcoma of the Liver with Intraatrial Metastasis]Koji Minami, Masahiko Sakoda, Satoshi Iino, et al.Surgical Case Reports|March 4, 2024
Successful subtotal gastrectomy and hepatectomy for HER2-positive gastric cancer with liver metastasis after trastuzumab-based chemotherapy: a case reportYuki Hirase, Takaaki Arigami, Yota Kawasaki, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 4, 2025
RBBP8 Is a Prognostic Biomarker Associated With Response to Immune Checkpoint Inhibitors in Advanced Gastric CancerTaiki Nakashima, Ryu Matsumoto, Kiyonori Tanoue, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 26, 2016
[A Case of Recurred Gastric Cancer of the Anastomosis Completely Responding to Docetaxel, Cisplatin, and S-1 Triplet Therapy]Yusuke Tsuruda, Sumiya Ishigami, Yoshikazu Uenosono, et al.Anticancer Research|December 31, 2024
Circulating Pre-microRNA-488 in Blood Is a Potential Prognostic Biomarker in Gastric CancerYusuke Tsuruda, Takaaki Masuda, Yoshiki Hiraki, et al.Plos One|October 23, 2020
Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMTQingjiang Hu, Takaaki Masuda, Shotaro Kuramitsu, et al.Surgery Today|May 11, 2022
A prognostic scoring system for conversion surgery after trastuzumab-based chemotherapy for human epidermal growth factor receptor 2-positive advanced gastric cancerTakaaki Arigami, Daisuke Matsushita, Keishi Okubo, et al.Pageof 6